The Greek Deal.com
More News
ECONOMY
ECONOMY
OECD
Strong economy and persistent inflation - The recommendations
The OECD forecasts growth of 2.2% in 2025 and 2.5% in 2026 for Greece, expecting that the increase in disposable income will support consumption, while the "tight" labour market and increases in the minimum wage will support wages.
BUSINESS
BUSINESS
Ideal Holdings
Announcement about Barba Stathis takeover
Ideal Holdings responds to the publications that talk about a possible takeover of Barba Stathis following a letter from the Hellenic Capital Market Commission.
BUSINESS
BUSINESS
GEK Terna
Contribution of €4.8 billion to Greece's GDP
The substantial contribution of GEK TERNA Group to the national economy and the Greek society was once again highlighted through a study "Socio-Economic Impact Assessment (SEIA) for the period 2022-2023".
BUSINESS
BUSINESS
TRADE ESTATES
Preliminary agreement with Lamda Development for the Retail Park
Lamda Development and Trade Estate have signed the notarial contract for the sale of the retail park within the commercial hub for a total price of €31 million.
MARKETS
MARKETS
Athens Stock Exchange
Anticipating reaction after yesterday's plunge
Cautious moves on the Stock Exchange after yesterday's sharp correction.
MARKETS
MARKETS
Public Debt Management Agency
Auction of €625 million of 3-month Τ-Bills
Auction of three-month treasury bills of the Hellenic Republic by the Public Debt Management Agency.
MARKETS
MARKETS
Hellenic Capital Market Commission
Prelium's operating license revoked
Hellenic Capital Market Commission suspended the license of Prelium SA until further notice.
BUSINESS
BUSINESS
TITAN
Investments in new technologies and innovation at the Kamari plant
Titan invests €26 million in Kamari plant in order to become of the "greenest" cement factories in Europe.
POLITICS
POLITICS
Kyriakos Mitsotakis
Meets with managing directors of Big Pharmaceutical Companies
Greek Prime Minister will meet CEOs of pharmaceutical companies in the context of their biannual meeting, better known as the Biopharmaceutical CEOs Roundtable (BCR).
BUSINESS
BUSINESS
Dimand
Return to profitability
Dimand had a strong operating performance in fiscal year 2023 according to the results announced.
More News